SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

JACKSON DAVID

(Last)

(First)

(Middle)

C/O ADOLOR CORP

700 PENNSYLVANIA DR

(Street)

EXTON

19341

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/13/2007

3. Issuer Name and Ticker or Trading Symbol
ADOLOR CORP [ ADLR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Sr V.P & Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	828	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Deferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	5,000	$0	D
Employee Stock Option (right to buy)	⁽²⁾	06/13/2017	Common Stock	40,000	$3.83	D
Employee Stock Option (right to buy)	⁽²⁾	01/06/2014	Common Stock	50,000	$20.49	D
Employee Stock Option (right to buy)	⁽²⁾	10/27/2013	Common Stock	20,000	$18.86	D
Employee Stock Option (right to buy)	⁽³⁾	01/09/2013	Common Stock	23,200	$13.15	D
Employee Stock Option (right to buy)	⁽³⁾	01/10/2012	Common Stock	16,844	$16.73	D
Employee Stock Option (right to buy)	⁽³⁾	04/12/2012	Common Stock	20,000	$9.85	D
Employee Stock Option (right to buy)	⁽³⁾	05/14/2012	Common Stock	25,000	$13.53	D
Employee Stock Option (right to buy)	⁽³⁾	01/29/2011	Common Stock	50,000	$21.25	D
Employee Stock Option (right to buy)	⁽³⁾	01/29/2011	Common Stock	30,000	$16.25	D
Employee Stock Option (right to buy)	⁽³⁾	12/04/2011	Common Stock	20,000	$14.62	D

Explanation of Responses:

1. Shares of Deferred Stock vest on the third anniversary of the grant date subject to accelerated vesting on date alvimopan NDA is approved for use in POI or Change of Control as defined in the Adolor Corporation 2003 Stock-Based Incentive Compensation Plan.

2. The options vest in equal parts of 1/48th of the total per month beginning one month after the date of grant.

3. Fully vested.

	/s/David Jackson	09/13/2007
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.